Crossvault Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-20,960
| Closed | -$1.84M | – | 62 |
|
|
2017
Q1 | $1.84M | Buy |
20,960
+365
| +2% | +$32K | 1.14% | 31 |
|
|
2016
Q4 | $1.71M | Sell |
20,595
-750
| -4% | -$62.1K | 1.15% | 31 |
|
|
2016
Q3 | $1.98M | Buy |
21,345
+3,275
| +18% | +$303K | 1.38% | 30 |
|
|
2016
Q2 | $1.41M | Sell |
18,070
-75
| -0.4% | -$5.84K | 0.99% | 30 |
|
|
2016
Q1 | $1.5M | Buy |
18,145
+3,740
| +26% | +$309K | 1.1% | 30 |
|
|
2015
Q4 | $1.51M | Buy |
14,405
+1,895
| +15% | +$199K | 1.07% | 32 |
|
|
2015
Q3 | $1.32M | Buy |
12,510
+5,435
| +77% | +$573K | 1.03% | 31 |
|
|
2015
Q2 | $968K | Buy |
7,075
+975
| +16% | +$133K | 0.77% | 32 |
|
|
2015
Q1 | $760K | Sell |
6,100
-8,680
| -59% | -$1.08M | 0.61% | 39 |
|
|
2014
Q4 | $1.34M | Sell |
14,780
-225
| -1% | -$20.3K | 1.17% | 31 |
|
|
2014
Q3 | $1.08M | Buy |
15,005
+1,747
| +13% | +$126K | 1.02% | 31 |
|
|
2014
Q2 | $825K | Sell |
13,258
-525
| -4% | -$32.7K | 0.77% | 37 |
|
|
2014
Q1 | $940K | Buy |
13,783
+1,500
| +12% | +$102K | 0.91% | 34 |
|
|
2013
Q4 | $864K | Buy |
+12,283
| New | +$864K | 0.83% | 35 |
|